Epinephrine Injector


Subject: Epinephrine Injector
Solicitation Number: SPE2D2-26-R-0009
Notice Type: SOLICIT
NAICS: 325412
Notice Published: 10-01-26
Response Due: 11-02-26

Agency: DEPT OF DEFENSE
Office: DEFENSE LOGISTICS AGENCY
Contact: Jeremy Brown This email address is being protected from spambots. You need JavaScript enabled to view it. Ph: (445) 737-5419
Office Address: PHILADELPHIA, PA 19111


Related Notices:
        04-29-26 PRESOL


Click for official SAM (FBO) notice, additional information, and accompanying attachments

The Defense Logistics Agency is issuing a solicitation for a national requirements contract for Epinephrine Injectors. Procurement details follow. Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (This email address is being protected from spambots. You need JavaScript enabled to view it.) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2026.